• Publications
  • Influence
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
BackgroundThere has been an increase in 'risk sharing' schemes for pharmaceuticals between healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach toExpand
  • 214
  • 18
Economics of myocardial perfusion imaging in Europe--the EMPIRE Study.
BACKGROUND Physicians use myocardial perfusion imaging to a variable extent in patients presenting with possible coronary artery disease. There are few clinical data on the most cost-effectiveExpand
  • 175
  • 12
Diffusion of e-health innovations in ‘post-conflict’ settings: a qualitative study on the personal experiences of health workers
BackgroundTechnological innovations have the potential to strengthen human resources for health and improve access and quality of care in challenging ‘post-conflict’ contexts. However, analyses onExpand
  • 31
  • 9
  • PDF
Links between Pharmaceutical R&D Models and Access to Affordable Medicines
Each patient in the European Union has a right of access to care. National governments face the challenge to balance resources against healthcare demand to ensure that populations enjoy equitableExpand
  • 25
  • 8
  • PDF
Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications
Introduction: European countries need to learn from each other to address unsustainable increases in pharmaceutical expenditures. Objective: To assess the influence of the many supply and demand-sideExpand
  • 106
  • 7
Ongoing pharmaceutical reforms in France: implications for key stakeholder groups.
The rapid rise in pharmaceutical costs in France has been driven by new technologies and the growing prevalence of chronic diseases as well as considerable prescribing freedom and choice of physicianExpand
  • 117
  • 5
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review
Pharmaceutical expenditure has increased rapidly across many Organisation for Economic Cooperation and Development (OECD) countries over the past three decades. This growth is an increasing concernExpand
  • 62
  • 5
  • PDF
Initiatives to Reduce Nonprescription Sales and Dispensing of Antibiotics: Findings and Implications
Objective: Irrational use of antimicrobials is a major driver of antimicrobial resistance, exacerbated by dispensing antibiotics without a prescription. Our previous study suggested this was aExpand
  • 34
  • 5
Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature
Background: Knowledge, perceptions and prescribing behaviour are key to antibiotic prescribing. The aim of this paper is to systematically review this. Method: An extensive literature search fromExpand
  • 106
  • 4
  • PDF
International variability in the reimbursement of cancer drugs by publically funded drug programs.
PURPOSE Evaluate inter-country variability in the reimbursement of publically funded cancer drugs, and identify factors such as cost containment measures that may contribute to variability. METHODSExpand
  • 65
  • 4
  • PDF